Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

NCT03159091 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03159091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
June 16, 2017
Completion date
April 25, 2019
Enrollment
238 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease